Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
[Therapeutic Developments in Eosinophilic Esophagitis]
Javier Molina-Infante1,2, Alfredo J Lucendo2,3,4
1Servicio de Aparato Digestivo, Hospital Universitario de Cáceres, Cáceres, España. Servicio de Aparato Digestivo Hospital Universitario de Cáceres Cáceres España.
None:
Eosinophilic esophagitis (EoE) is a chronic immunoallergic disorder caused, in most cases, by a non-IgE mediated food allergy. Its current prevalence exceeds 1 case per 1,000 inhabitants in Spain and Europe, while it is emerging in South America. This review attempts to update the therapeutic novelties that have appeared in the last 5 years for either induction or maintenance in this pathology, including new anti-acid drugs (potassium competitive acid blockers), simplified optimization of dietary schemes, novel swallowed topical corticosteroids specifically developed for esophageal delivery, as well as the incorporation of biologic agents into the therapeutic algorithm of the disease. Endoscopic dilation continues to be a safe and effective complement for symptomatic improvement, in combination with anti-inflammatory treatments for the disease.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

